PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 250 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $414 | -13.8% | 13,476 | +8.4% | 0.04% | -14.6% |
Q4 2022 | $480 | -99.9% | 12,430 | -7.4% | 0.05% | -45.5% |
Q1 2020 | $450,000 | +56.2% | 13,420 | +111.2% | 0.09% | +91.3% |
Q4 2019 | $288,000 | -18.2% | 6,353 | -21.5% | 0.05% | -22.0% |
Q2 2019 | $352,000 | -68.5% | 8,089 | -72.5% | 0.06% | -67.8% |
Q1 2019 | $1,119,000 | +142.7% | 29,412 | +191.1% | 0.18% | +69.4% |
Q1 2017 | $461,000 | +44.5% | 10,105 | +8.7% | 0.11% | +27.1% |
Q3 2016 | $319,000 | – | 9,300 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |